Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)
China
· Delayed Price · Currency is CNY 4.900
+0.060 (1.24%)
Mar 10, 2026, 3:00 PM CST
SHA:603718 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,194 | 4,546 | 7,046 | 6,324 | 9,853 | 8,121 | Upgrade
|
| Market Cap Growth | -34.03% | -35.48% | 11.42% | -35.82% | 21.33% | -1.48% | Upgrade
|
| Enterprise Value | 2,906 | 4,343 | 6,992 | 6,101 | 9,857 | 8,043 | Upgrade
|
| Last Close Price | 4.90 | 6.84 | 10.55 | 9.61 | 14.98 | 12.34 | Upgrade
|
| PE Ratio | 18.47 | 26.56 | 112.07 | 52.00 | 182.95 | 909.73 | Upgrade
|
| Forward PE | - | 44.04 | 44.04 | 44.04 | 44.04 | 44.04 | Upgrade
|
| PS Ratio | 12.97 | 16.77 | 29.27 | 21.08 | 28.37 | 31.34 | Upgrade
|
| PB Ratio | 1.88 | 2.67 | 6.00 | 5.69 | 9.98 | 8.44 | Upgrade
|
| P/TBV Ratio | 6.94 | 9.11 | 7.39 | 7.51 | 14.46 | 11.21 | Upgrade
|
| P/FCF Ratio | 59.43 | 119.37 | - | 23.16 | 1683.00 | 60.80 | Upgrade
|
| P/OCF Ratio | 51.89 | 97.82 | - | 21.59 | 225.82 | 48.43 | Upgrade
|
| EV/Sales Ratio | 11.79 | 16.02 | 29.05 | 20.34 | 28.38 | 31.04 | Upgrade
|
| EV/EBITDA Ratio | 23.66 | 81.52 | 239.78 | 107.30 | 125.10 | 385.63 | Upgrade
|
| EV/EBIT Ratio | 33.73 | 234.40 | - | 388.87 | 450.14 | - | Upgrade
|
| EV/FCF Ratio | 54.06 | 114.03 | - | 22.34 | 1683.62 | 60.22 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.23 | 0.14 | 0.48 | 0.49 | Upgrade
|
| Debt / EBITDA Ratio | 0.15 | 0.31 | 8.16 | 2.51 | 6.01 | 22.39 | Upgrade
|
| Debt / FCF Ratio | 0.34 | 0.46 | - | 0.58 | 81.59 | 3.50 | Upgrade
|
| Net Debt / Equity Ratio | -0.27 | -0.29 | -0.07 | -0.21 | -0.06 | -0.06 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.76 | -9.38 | -2.82 | -4.13 | -0.77 | -2.58 | Upgrade
|
| Net Debt / FCF Ratio | -8.41 | -13.12 | 5.08 | -0.86 | -10.41 | -0.40 | Upgrade
|
| Asset Turnover | 0.14 | 0.16 | 0.15 | 0.18 | 0.19 | 0.15 | Upgrade
|
| Inventory Turnover | 0.83 | 1.40 | 0.97 | 0.87 | 1.23 | 1.22 | Upgrade
|
| Quick Ratio | 6.84 | 6.27 | 1.06 | 1.55 | 0.99 | 0.92 | Upgrade
|
| Current Ratio | 7.63 | 6.90 | 1.35 | 2.07 | 1.46 | 1.16 | Upgrade
|
| Return on Equity (ROE) | 13.95% | 12.62% | 4.38% | 10.55% | 4.69% | -3.29% | Upgrade
|
| Return on Assets (ROA) | 3.14% | 0.66% | -0.26% | 0.58% | 0.75% | -1.34% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.77% | 1.41% | -0.59% | 1.47% | 1.91% | -4.31% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.00% | 1.10% | -0.50% | 1.30% | 1.90% | -3.30% | Upgrade
|
| Earnings Yield | 5.36% | 3.77% | 0.89% | 1.92% | 0.55% | 0.11% | Upgrade
|
| FCF Yield | 1.68% | 0.84% | -0.23% | 4.32% | 0.06% | 1.65% | Upgrade
|
| Dividend Yield | 1.62% | 1.15% | 0.27% | 0.59% | - | 0.03% | Upgrade
|
| Payout Ratio | 30.67% | 12.60% | 60.28% | 0.56% | 5.54% | 43.29% | Upgrade
|
| Buyback Yield / Dilution | 3.04% | -4.72% | 1.77% | 4.93% | 24.58% | -46.92% | Upgrade
|
| Total Shareholder Return | 4.66% | -3.57% | 2.04% | 5.52% | 24.58% | -46.89% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.